Oscar Health is trading 4.2% down at $29.32 as investors react to mounting Affordable Care Act (ACA) exchange uncertainty and sector-wide cost pressures.

  • Recent downgrades flag a potential 30% enrollment hit in 2026 and rising medical costs across the industry.
  • Peers like Elevance and Molina have highlighted higher exchange utilization and pulled guidance, weighing heavily on ACA-focused insurers.